幽门螺杆菌与胃癌:一种存在争议的关系。

Eradication of and Gastric Cancer: A Controversial Relationship.

作者信息

Piscione Mariagrazia, Mazzone Mariangela, Di Marcantonio Maria Carmela, Muraro Raffaella, Mincione Gabriella

机构信息

Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.

出版信息

Front Microbiol. 2021 Feb 4;12:630852. doi: 10.3389/fmicb.2021.630852. eCollection 2021.

Abstract

Worldwide, gastric cancer (GC) represents the fifth cancer for incidence, and the third as cause of death in developed countries. Indeed, it resulted in more than 780,000 deaths in 2018. appears to be responsible for the majority of these cancers. On the basis of recent studies, and either alone or combined with additional etiological factors, is considered a "type I carcinogen." Over recent decades, new insights have been obtained into the strategies that have been adopted by to survive the acidic conditions of the gastric environment, and to result in persistent infection, and dysregulation of host functions. The multistep processes involved in the development of GC are initiated by transition of the mucosa into chronic non-atrophic gastritis, which is primarily triggered by infection with . This gastritis then progresses into atrophic gastritis and intestinal metaplasia, and then to dysplasia, and following Correa's cascade, to adenocarcinoma. The use of antibiotics for eradication of can reduce the incidence of precancerous lesions only in the early stages of gastric carcinogenesis. Here, we first survey the etiology and risk factors of GC, and then we analyze the mechanisms underlying tumorigenesis induced by , focusing attention on virulence factor CagA, inflammation, oxidative stress, and ErbB2 receptor tyrosine kinase. Moreover, we investigate the relationships between eradication therapy and other diseases, considering not only cardia (upper stomach) cancers and Barrett's esophagus, but also asthma and allergies, through discussion of the "hygiene hypothesis. " This hypothesis suggests that improved hygiene and antibiotic use in early life reduces microbial exposure, such that the immune response does not become primed, and individuals are not protected against atopic disorders, asthma, and autoimmune diseases. Finally, we overview recent advances to uncover the complex interplay between and the gut microbiota during gastric carcinogenesis, as characterized by reduced bacterial diversity and increased microbial dysbiosis. Indeed, it is of particular importance to identify the bacterial taxa of the stomach that might predict the outcome of gastric disease through the stages of Correa's cascade, to improve prevention and therapy of gastric carcinoma.

摘要

在全球范围内,胃癌(GC)是发病率排名第五的癌症,在发达国家是导致死亡的第三大癌症。事实上,2018年胃癌导致了超过78万人死亡。幽门螺杆菌似乎是这些癌症的主要病因。根据最近的研究,幽门螺杆菌单独或与其他病因因素结合,被认为是一种“Ⅰ类致癌物”。近几十年来,人们对幽门螺杆菌在胃环境酸性条件下存活、导致持续感染以及宿主功能失调所采用的策略有了新的认识。胃癌发生的多步骤过程始于黏膜转变为慢性非萎缩性胃炎,这主要由幽门螺杆菌感染引发。然后这种胃炎进展为萎缩性胃炎和肠化生,接着发展为发育异常,并按照科雷亚级联反应发展为腺癌。使用抗生素根除幽门螺杆菌仅能在胃癌发生的早期阶段降低癌前病变的发生率。在此,我们首先概述胃癌的病因和危险因素,然后分析幽门螺杆菌诱导肿瘤发生的潜在机制,重点关注毒力因子CagA、炎症、氧化应激和表皮生长因子受体2(ErbB2)受体酪氨酸激酶。此外,我们通过讨论“卫生假说”来研究根除幽门螺杆菌治疗与其他疾病之间的关系,不仅考虑贲门(胃上部)癌和巴雷特食管,还包括哮喘和过敏。该假说认为,早年卫生条件改善和抗生素使用减少了微生物暴露,使得免疫反应无法得到激发,个体无法预防特应性疾病、哮喘和自身免疫性疾病。最后,我们概述了近期在揭示胃癌发生过程中幽门螺杆菌与肠道微生物群之间复杂相互作用方面的进展,其特征是细菌多样性降低和微生物失调增加。事实上,识别胃内可能通过科雷亚级联反应各阶段预测胃病结果的细菌分类群,对于改善胃癌的预防和治疗尤为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c6/7889593/b4caa9d3a315/fmicb-12-630852-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索